These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33155897)

  • 1. Prediction Models and Scores in Pulmonary Hypertension: A Review.
    Mouratoglou SA; Bayoumy AA; Noordegraaf AV
    Curr Pharm Des; 2021; 27(10):1266-1276. PubMed ID: 33155897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification in pulmonary arterial hypertension.
    Weatherald J; Boucly A; Sitbon O
    Curr Opin Pulm Med; 2018 Sep; 24(5):407-415. PubMed ID: 30004992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
    Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
    J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.
    Lokhorst C; van der Werf S; Berger RMF; Douwes JM
    Front Cardiovasc Med; 2022; 9():1035453. PubMed ID: 36440049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension.
    Kanwar M; Raina A; Lohmueller L; Kraisangka J; Benza R
    Curr Hypertens Rep; 2019 Apr; 21(6):45. PubMed ID: 31025123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.
    Xanthouli P; Koegler M; Marra AM; Benjamin N; Fischer L; Eichstaedt CA; Harutyunova S; Nagel C; Grünig E; Egenlauf B
    Respir Res; 2020 May; 21(1):127. PubMed ID: 32448256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk stratification methods and their significance in pulmonary arterial hypertension].
    Avdeev SN; Tsareva NA
    Ter Arkh; 2019 Sep; 91(9):150-157. PubMed ID: 32598827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.
    Sonnweber T; Tymoszuk P; Steringer-Mascherbauer R; Sigmund E; Porod-Schneiderbauer S; Kohlbacher L; Theurl I; Lang I; Weiss G; Löffler-Ragg J
    BMC Pulm Med; 2023 Apr; 23(1):143. PubMed ID: 37098543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment in pulmonary arterial hypertension.
    Raina A; Humbert M
    Eur Respir Rev; 2016 Dec; 25(142):390-398. PubMed ID: 27903661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
    Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
    Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification in pulmonary arterial hypertension using Bayesian analysis.
    Kanwar MK; Gomberg-Maitland M; Hoeper M; Pausch C; Pittrow D; Strange G; Anderson JJ; Zhao C; Scott JV; Druzdzel MJ; Kraisangka J; Lohmueller L; Antaki J; Benza RL
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32366491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Risk of Disease Progression in Pulmonary Arterial Hypertension: Insights from an International Survey of Clinical Practice.
    Simons JE; Mann EB; Pierozynski A
    Adv Ther; 2019 Sep; 36(9):2351-2363. PubMed ID: 31313097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.
    Bruni C; De Luca G; Lazzaroni MG; Zanatta E; Lepri G; Airò P; Dagna L; Doria A; Matucci-Cerinic M
    Eur J Intern Med; 2020 Aug; 78():17-25. PubMed ID: 32540411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    Stolfo D; Barbisan D; Ameri P; Lombardi CM; Monti S; Driussi M; Zovatto IC; Gentile P; Howard L; Toma M; Pagnesi M; Collini V; Bauleo C; Guglielmi G; Adamo M; D'Angelo L; Nalli C; Sciarrone P; Moschella M; Zorzi B; Vecchiato V; Milani M; Di Poi E; Airò E; Metra M; Garascia A; Sinagra G; Lo Giudice F
    J Heart Lung Transplant; 2023 Aug; 42(8):1082-1092. PubMed ID: 37005100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Novel Therapies of Pulmonary Arterial Hypertension.
    Nabeh OA; Saud AI; Amin B; Khedr AS; Amr A; Faoosa AM; Esmat E; Mahmoud YM; Hatem A; Mohamed M; Osama A; Soliman YMA; Elkorashy RI; Elmorsy SA
    Am J Cardiovasc Drugs; 2024 Jan; 24(1):39-54. PubMed ID: 37945977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
    Vraka A; Yerly P; Aubert JD
    Respiration; 2022; 101(6):565-576. PubMed ID: 35045412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.